Powering microbiome discovery

Fast, reliable microbiome analysis using cutting-edge genomics and informatics.

Diversigen represents over a century of microbiome experience demonstrated by more than 300 scientific publications and over 100,000 citations in respected scientific journals. 

HOW WE STUDY THE MICROBES LIVING IN YOUR GUT

Dan Knights PhD

Fast. Accurate. Predictive.

Accelerate Your Discoveries

Diversigen offers fast, reliable microbiome analysis using cutting-edge genomics and informatics. We help customers with study design and collection through to data generation and full custom analysis.

Microbiome Sample analysis and sequencing
Expert microbiome analysis

Precise. Controlled. Scaleable.

Expert Microbiome Analysis

Quality is everything.

We control every step of microbiome analysis, from the moment your samples are collected to the final data analysis.

Iterate faster. Get insight sooner.

Our platform is designed around generating fast, accurate, massive data sets to help you iterate the scientific process and get to insights faster.

Don't diagnose...Predict.

Diversigen combines meticulous sample processing and DNA sequencing with machine learning to help you discover the next breakthrough.

Neutral. Stable. Reproducible. 

Samples not collected yet?

Ask about OMNIgene® collection kits from our sister company, DNA Genotek. Take a ‘snapshot’ of the in vivo state right at the moment of collection. Ensure your microbiome profiles represent the phenotype of interest, not artifacts of overgrowth or degradation.

OMNIgene OM-200 collection kits

In the news

Highlights from the Crohn’s and Colitis panel

“Crohn’s disease and Colitis collectively are inflammatory bowel diseases (IBD). These inflammatory diseases impact the gastrointestinal tract (although not exclusively gastrointestinal tract). Most of these diseases can have an autoimmune component, particularly Crohn’s disease. Crohn’s disease can affect any part of the gastrointestinal tract anywhere from the mouth to the

Read More

Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board

Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board Joins Diversigen’s Scientific Advisory Board Leading Microbiome Researcher Dr. Eric Pamer   Joins Diversigen’s Scientific Advisory Board PAUL, MN, January 25, 2021 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc.  (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor

Read More

Discover where our services can take you.

Diversigen provides services and generates data for research purposes only.  Not all services are available in all regions.